Responses
Regular and Young Investigator Award Abstracts
Other
1418 Treatment-free survival in patients with advanced melanoma and non-small cell lung cancer receiving immune checkpoint inhibitors: real-world outcomes over a 3-year timespan
Compose a Response to This Article
Other responses
No responses have been published for this article.